Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication - Sorbonne Université
Journal Articles Open Forum Infectious Diseases Year : 2022

Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication

Fabrice Uhel
Alexandre Mebazaa
  • Function : Author
Benjamin Chousterman
Ahmed El Kalioubie
  • Function : Author
Sophie Six
  • Function : Author
Pauline Coulon
  • Function : Author
Nadia Anguel
  • Function : Author
Charles Damoisel
  • Function : Author
Charlotte Mussini
  • Function : Author
Alban Villate
  • Function : Author
Jean-Christophe Navellou
  • Function : Author
Christophe Girault
  • Function : Author
Carole Cassagne
  • Function : Author
Olivier Augereau
  • Function : Author
Francoise Dromer
  • Function : Author
Dea Garcia-Hermoso
Olivier Lortholary
  • Function : Author
Alexandre Alanio

Abstract

We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus up to 95% in India), hematological malignancies (35% versus 1%), anatomical sites (12% versus >80% rhino-orbito-cerebral) and prognosis (88% mortality versus <50%).

Domains

Virology
Fichier principal
Vignette du fichier
ofab566.pdf (296.4 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence

Dates and versions

hal-03962472 , version 1 (09-02-2023)

Licence

Identifiers

Cite

François Danion, Valérie Letscher-Bru, Juliette Guitard, Karine Sitbon, Sarah Dellière, et al.. Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication. Open Forum Infectious Diseases, 2022, 9 (2), pp.180-190. ⟨10.1093/ofid/ofab566⟩. ⟨hal-03962472⟩
100 View
33 Download

Altmetric

Share

More